P. Mols et al., DOSE DEPENDENCY OF AMINOPHYLLINE EFFECTS ON HEMODYNAMIC AND VENTRICULAR-FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, Chest, 103(6), 1993, pp. 1725-1731
The effects of aminophylline on pulmonary vascular tone, systemic hemo
dynamics, and ventricular ejection fractions reported in the literatur
e show some discrepancies. We therefore studied in COPD patients the e
ffects of aminophylline on hemodynamics, on ventricular ejection fract
ions, and on systolic and diastolic functions of each ventricle, and w
e measured simultaneously the blood level of the drug. The analysis of
the data revealed a relationship between the blood level of aminophyl
line and the variations of right ventricular ejection fraction (RVEF)
(r = 0.83, p = 0.005), left ventricular ejection fraction (LVEF) (r =
0.76, p = 0.017), pulmonary vascular resistance index (PVRI) (r = -0.5
8, p = 0.096), systemic vascular resistance index (SVRI) (r = -0.60, p
= 0.08), and right ventricular peak systolic pressure/end-systolic vo
lume index (RVPSP/ESVI) (r = 0.75, p = 0.02). Modifications of ejectio
n fractions and vascular resistance indices were correlated for both v
entricles (RVFF vs PVRI, r= -0.77, p = 0.01; LVEF vs SVRI, r = -0.76,
p = 0.02). Finally, RVEF modification was also correlated to RVPSP/ESV
I variation (r = 0.78, p = 0.01). These results suggest that even with
in the therapeutic range (10 to 20 mg/L), the effects of aminophylline
seemed to depend on its blood level. This dose dependency could expla
in the contradictory data reported in the literature concerning the ef
fects of aminophylline on pulmonary and systemic hemodynamics and on v
entricular function.